All lobbying filings

Holland & Knight LLP

Holland & Knight LLP filed a Q4 report for Acadia Pharmaceuticals Inc. on January 13, 2026, reporting $20,000 in lobbying income.

Lobbying for Acadia Pharmaceuticals Inc. · Biopharmaceutical company

As filed: HOLLAND & KNIGHT LLP for ACADIA PHARMACEUTICALS INC.

All filings by Holland & Knight LLP · Everything Acadia Pharmaceuticals Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 13, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.